P-R Herzig & Co Position In Amgen (AMGN) Was Increased; Nokia (NOK) Shareholder Folketrygdfondet Cut Position by $35.66 Million as Share Value Rose

June 24, 2018 - By Clifton Ray

Nokia Corporation (NYSE:NOK) Logo

Folketrygdfondet decreased its stake in Nokia Corp (NOK) by 22.47% based on its latest 2018Q1 regulatory filing with the SEC. Folketrygdfondet sold 7.13M shares as the company’s stock rose 3.54% while stock markets declined. The institutional investor held 24.61 million shares of the radio and television broadcasting and communications equipment company at the end of 2018Q1, valued at $134.61 million, down from 31.74 million at the end of the previous reported quarter. Folketrygdfondet who had been investing in Nokia Corp for a number of months, seems to be less bullish one the $33.44 billion market cap company. The stock increased 0.68% or $0.04 during the last trading session, reaching $5.95. About 14.08 million shares traded. Nokia Corporation (NYSE:NOK) has declined 4.06% since June 24, 2017 and is downtrending. It has underperformed by 16.63% the S&P500. Some Historical NOK News: 25/04/2018 – Nokia’s Reported Net Loss Seen Narrowing — Earnings Preview; 29/03/2018 – Nokia to cut 353 jobs in Finland; 07/05/2018 – Nokia Buys SpaceTime Insight to Expand Its IoT Software Portfolio and Accelerate Vertical Application Devt; 30/05/2018 – NOKIA OYJ – AGM RESOLVED TO DISTRIBUTE DIVIDEND OF EUR 0.19 PER SHARE FOR FINANCIAL YEAR 2017; 15/05/2018 – Nokia Corp Appoints Sri Reddy as Co-President of IP/Optical Networks Business; 27/03/2018 – HUAWEI SAYS TO PRICE NEW P20 MOBILE PHONE BASIC MODEL AT 649 EURO, P20 PRO MODEL AT 899 EUROS; 30/05/2018 – NOKIA OYJ – AGM RESOLVED TO ELECT TEN MEMBERS TO BOARD OF NOKIA; 26/04/2018 – NOKIA CEO SEES U.S. 5G COMMERCIAL ROLLOUTS STARTING IN 2H 2018; 07/05/2018 – Nokia and SFR first in France to conduct a 5G New Radio call using 3.5 GHz spectrum; 15/05/2018 – Nokia appoints Sri Reddy as co-president of IP/Optical Networks (ION) business group and as member of the Nokia Group Leadership Team

P-R Herzig & Co increased its stake in Amgen Inc (AMGN) by 23.49% based on its latest 2018Q1 regulatory filing with the SEC. P-R Herzig & Co bought 2,505 shares as the company’s stock declined 5.44% with the market. The institutional investor held 13,170 shares of the biological products (no diagnostic substances) company at the end of 2018Q1, valued at $2.25M, up from 10,665 at the end of the previous reported quarter. P-R Herzig & Co who had been investing in Amgen Inc for a number of months, seems to be bullish on the $122.52B market cap company. The stock decreased 0.45% or $0.84 during the last trading session, reaching $185.15. About 11.15M shares traded or 233.08% up from the average. Amgen Inc. (NASDAQ:AMGN) has risen 14.68% since June 24, 2017 and is uptrending. It has outperformed by 2.11% the S&P500. Some Historical AMGN News: 19/04/2018 – $NVS CEO Vas Narasimhan found his replacement as development chief — at $AMGN John Tsai –; 29/03/2018 – Amgen: BLINCYTO Is Only FDA Approved Therapy for Minimal Residual Disease; 17/05/2018 – Novartis and Amgen Announce FDA Approval of Aimovig for Migraine Prevention; 23/03/2018 – AMGEN-ALLERGAN: ABP 980 FOR TREATMENT OF THREE TYPES OF CANCER; 08/05/2018 – LUPIN SUBMITS NEW DRUG APPLICATION FOR ETANERCEPT BIOSIMILAR; 24/04/2018 – Amgen, Inc. Cuts 2018 View To EPS $11.30-EPS $12.28; 22/03/2018 – STAT Plus: Amgen employee in Denmark violated the law by posting a press release on LinkedIn; 29/03/2018 – FDA Approves BLINCYTO® (blinatumomab) To Treat Minimal Residual Disease-Positive B-Cell Precursor Acute Lymphoblastic Leukemia In Adults And Children; 05/04/2018 – AbbVie Announces Global Resolution of HUMIRA® (adalimumab) Patent Disputes with Samsung Bioepis; 10/03/2018 – Regeneron and Sanofi Announce Plans to Make Praluent® (alirocumab) More Accessible and Affordable for Patients with the Greatest Health Risk and Unmet Need

Among 25 analysts covering Nokia (NYSE:NOK), 12 have Buy rating, 3 Sell and 10 Hold. Therefore 48% are positive. Nokia had 53 analyst reports since August 26, 2015 according to SRatingsIntel. The firm has “Underperform” rating by BNP Paribas given on Friday, September 22. On Thursday, February 18 the stock rating was maintained by JP Morgan with “Overweight”. The rating was reinitiated by Morgan Stanley on Tuesday, February 16 with “Equal-Weight”. The firm has “Hold” rating by Charter Equity given on Tuesday, October 31. The rating was maintained by BMO Capital Markets on Friday, October 27 with “Hold”. M Partners upgraded Nokia Corporation (NYSE:NOK) on Friday, February 2 to “Buy” rating. The stock of Nokia Corporation (NYSE:NOK) earned “Sell” rating by Danske Bank on Wednesday, January 25. The rating was upgraded by Morgan Stanley to “Overweight” on Tuesday, February 7. The stock of Nokia Corporation (NYSE:NOK) has “Hold” rating given on Friday, February 2 by Cowen & Co. Citigroup initiated the shares of NOK in report on Thursday, June 8 with “Hold” rating.

More news for Nokia Corporation (NYSE:NOK) were recently published by: Seekingalpha.com, which released: “Verizon, Nokia hit 5G milestones with data sessions” on June 12, 2018. Globenewswire.com‘s article titled: “Nokia Corporation – Managers’ transactions” and published on June 20, 2018 is yet another important article.

Analysts await Nokia Corporation (NYSE:NOK) to report earnings on July, 26. They expect $0.05 earnings per share, down 44.44% or $0.04 from last year’s $0.09 per share. NOK’s profit will be $281.03 million for 29.75 P/E if the $0.05 EPS becomes a reality. After $0.02 actual earnings per share reported by Nokia Corporation for the previous quarter, Wall Street now forecasts 150.00% EPS growth.

Among 25 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 14 Hold. Therefore 44% are positive. Amgen Inc. had 89 analyst reports since August 3, 2015 according to SRatingsIntel. As per Thursday, February 25, the company rating was initiated by Citigroup. On Tuesday, December 15 the stock rating was upgraded by Morgan Stanley to “Overweight”. On Wednesday, April 5 the stock rating was downgraded by Jefferies to “Hold”. The rating was upgraded by Argus Research on Tuesday, January 23 to “Buy”. The stock has “Buy” rating by Cowen & Co on Thursday, February 1. Oppenheimer maintained the shares of AMGN in report on Friday, July 28 with “Buy” rating. The firm earned “Buy” rating on Monday, September 7 by UBS. The rating was maintained by BMO Capital Markets on Friday, February 2 with “Market Perform”. The stock of Amgen Inc. (NASDAQ:AMGN) has “Buy” rating given on Monday, February 8 by Argus Research. The firm has “Market Perform” rating given on Tuesday, September 1 by Raymond James.

More notable recent Amgen Inc. (NASDAQ:AMGN) news were published by: Fool.com which released: “Is Amgen Inc. (AMGN) a Buy?” on June 03, 2018, also Seekingalpha.com with their article: “EC grants full approval for Amgen’s Blincyto” published on June 19, 2018, Seekingalpha.com published: “Amgen Should Rebound On Aimovig And Kyprolis Revenue” on June 20, 2018. More interesting news about Amgen Inc. (NASDAQ:AMGN) were released by: Seekingalpha.com and their article: “Pick Up Amgen In 2018” published on May 31, 2018 as well as Nasdaq.com‘s news article titled: “Long-Term Investors Take Note — These 5 Big Pharma Companies Have the Best Pipelines” with publication date: June 24, 2018.

Investors sentiment decreased to 0.88 in Q1 2018. Its down 0.34, from 1.22 in 2017Q4. It dived, as 67 investors sold AMGN shares while 557 reduced holdings. 114 funds opened positions while 435 raised stakes. 502.72 million shares or 8.88% less from 551.71 million shares in 2017Q4 were reported. Kingfisher Cap Lc has invested 1.18% in Amgen Inc. (NASDAQ:AMGN). Parametric Assocs Limited Liability Co has 0.4% invested in Amgen Inc. (NASDAQ:AMGN). Burney invested in 0.16% or 15,219 shares. The New York-based Estabrook Mngmt has invested 0% in Amgen Inc. (NASDAQ:AMGN). Blue Fin reported 6,676 shares. Endurance Wealth Inc owns 34,172 shares for 0.98% of their portfolio. Etrade Capital Limited Co holds 0.06% or 10,447 shares. Cetera Limited Co stated it has 0.1% in Amgen Inc. (NASDAQ:AMGN). Signaturefd invested in 5,144 shares or 0.1% of the stock. Evanston Dba Evanston Advsr, a Illinois-based fund reported 47,110 shares. Two Sigma Securities Ltd Limited Liability Company has 0.03% invested in Amgen Inc. (NASDAQ:AMGN) for 34,964 shares. American Beacon Inc holds 1.97% or 1,090 shares. Aspen Investment Mgmt Inc stated it has 0.87% in Amgen Inc. (NASDAQ:AMGN). Schafer Cullen Capital Inc has 0.01% invested in Amgen Inc. (NASDAQ:AMGN) for 2,955 shares. Moreover, Hl Financial Ltd Liability Corp has 0.14% invested in Amgen Inc. (NASDAQ:AMGN) for 45,628 shares.

P-R Herzig & Co, which manages about $134.68 million and $49.74 million US Long portfolio, decreased its stake in General Electric Co (NYSE:GE) by 29,300 shares to 13,100 shares, valued at $177,000 in 2018Q1, according to the filing.

Since January 16, 2018, it had 0 insider buys, and 6 sales for $1.65 million activity.

Amgen Inc. (NASDAQ:AMGN) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>